Oncology

Study finds fewer women would support less frequent screening if they were found to be at lower risk.

Cell surface protein found to promote cancer growth.

Next generation chemotherapy may offer effective earlier treatment for disease.

Study finds shared decision making and accommodation of patient preferences improves quality.

Delivery system kills chemotherapy-resistant cancer stem cells and prevents secondary tumor formation.

Writer and neurologist Oliver Sacks confirms he has terminal cancer of the liver.

Experimental device offers non-invasive method to diagnose disease.

Activation of protein causes cells to change shape and become motile.

Enzyme associated with metabolic programming may lead to new treatments.

Study examines how side effects from commonly used antibiotics effect mitochondria of cancer cells.

Lenvima-treated patients experienced a median of 18.3 progression-free months.

Diabetics who took metformin saw a decreased chance of developing adenocarcinoma.

Annual rate of primary tumor removal has decreased since 1988.

Cells found to hijack vitamin D receptors to repair damage caused by therapy.

In 2014, the FDA approved notable new therapies for the treatment of cancer, bleeding disorders, inflammatory conditions, cystic fibrosis, pulmonary fibrosis, HIV, hepatitis C, multiple sclerosis, angioedema, and other conditions.

Trend reflects growing tobacco epidemic among women.

Genomic sequencing reveals effect of hepatitis on genetic mutations in tumors.

A recent study has identified how chronic hepatitis infection can pave the way to liver cancer.

Phase 3 trial for polycythemia vera drug significantly improved hematocrit control without the need for phlebotomy.

Progression-free survival improved from treatment during phase 3 trial.

Palbociclib inhibits molecules that promote cancer cell growth.

Research identifies how tumors resist current treatments.

Treatment was previously designated as a breakthrough therapy for bladder cancer.

The FDA today granted accelerated approval to a drug that treats breast cancer in postmenopausal women by attacking molecules that promote cancer cell growth.

Technology locates tumors otherwise obscured by dense breast tissue on a mammogram.

If you use erythropoiesis stimulating agents (ESAs) in your hospital or clinic, then here is a refresher of the ESA APPRISE Program.

Smokers have greater risk for recurrence of cancer.

Women diagnosed with polycystic ovary syndrome are more likely to develop heart disease, diabetes, and other chronic conditions than those without the hormone disorder.